Director General Li visits Italy, meets government officials, industry and private sector representatives
ROME, 22 October 2013 – On an official visit to Italy today, LI Yong, Director General of the United Nations Industrial Development Organization (UNIDO), was received by the Minister of Foreign Affairs, Emma Bonino.
During their discussions, the Director General expressed his appreciation for the strong support that UNIDO has traditionally received from Italy, and presented his vision of UNIDO in terms of inclusive and sustainable industrial development.
He also stressed his intention to strengthen UNIDO’s partnerships with all relevant counterparts in the development community, including the multilateral development banks and the private sector, and informed the minister of the positive meetings he had held with representatives of Italian industry.
Minister Bonino assured the Director General that Italy’s relationship with UNIDO was well-established and that she saw an important role for UNIDO in helping developing countries add value to their own resources and create local jobs, which would also generate opportunities for Italian companies. She welcomed the Director General’s initiative to approach the private sector in Italy, and stressed the importance her government placed on UNIDO’s cooperation with Italian companies. She also noted that the Italian economy’s SME-based structure also presented a useful model for many developing countries with similar structures, and that many Italian companies had a strong background in clean production technologies. Bonino expressed her country’s strong interest in a continued cooperation with UNIDO.
Director General Li also had meetings with representatives of the Confederation of Italian Industries (Confindustria), the Italian Banking Association (Associazione Bancaria Italiana – ABI), and major Italian companies, including the multinational oil and gas company, ENI (Ente Nazionale Idrocarbonico), the Barilla Group food company, the Fiat carmaker, as well as Novamont and IPACKIMA.